These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical and immunological considerations in Epstein-Barr virus-associated diseases. Andersson J. Scand J Infect Dis Suppl; 1996 Mar; 100():72-82. PubMed ID: 8860357 [Abstract] [Full Text] [Related]
8. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease]. Sauerbrei A, Sprössig M, Wutzler P, Färber I, Schweizer H, Swoboda R, Wilke J. Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167 [Abstract] [Full Text] [Related]
9. Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activity. Goldenberg GJ, Brandes LJ, Lau WH, Miller AB, Wall C, Ho JH. Cancer Treat Rep; 1985 Apr; 69(7-8):761-7. PubMed ID: 2990711 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus-mild acquired immune deficiency syndrome (EBV-MAIDS) in postsurgical sinusitis. Toffel PH, Christensen J. Am J Rhinol; 2002 Apr; 16(6):291-5. PubMed ID: 12512902 [Abstract] [Full Text] [Related]
11. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection. Wingate PJ, McAulay KA, Anthony IC, Crawford DH. J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950 [Abstract] [Full Text] [Related]
13. Cellular immune defects to Epstein-Barr virus-determined antigens in young males. Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT. Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337 [Abstract] [Full Text] [Related]
14. Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. A randomized trial. Stevens DA, Merigan TC. Arch Intern Med; 1980 Jan; 140(1):52-4. PubMed ID: 6153260 [Abstract] [Full Text] [Related]
15. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis]. Urazova LN, Podoplekin VD, Odintsova LN, Lepekhin AV. Lab Delo; 1989 Jan; (5):73-4. PubMed ID: 2473271 [Abstract] [Full Text] [Related]
16. [Analysis of viral capsid anti-antigen antibodies of the Epstein Barr virus in infectious mononucleosis. Comparative evaluation of a fluorescence method with classic methods]. Picerno G, Lari M, Fregoso F, Musmanno G. Quad Sclavo Diagn; 1983 Dec; 19(4):489-98. PubMed ID: 6330785 [Abstract] [Full Text] [Related]